Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial

• मुख्य लेखकों: Mustafa Erelel (लेखक), Mert Kaskal (लेखक), Ozlem Akbal-Dagistan (लेखक), Halim Issever (लेखक), Ahmet Serhan Dagistanli (लेखक), Hilal Balkanci (लेखक), Merve Sinem Oguz (लेखक), Aygun Qarayeva (लेखक), Meltem Culha (लेखक), Aybige Erturk (लेखक), Nur Sena Basarir (लेखक), Gokben Sahin (लेखक), Ali Yagiz Uresin (लेखक), Ahmet Ogul Araman (लेखक), Alpay Medetalibeyoglu (लेखक), Tufan Tukek (लेखक), Mustafa Oral Oncul (लेखक), Ayca Yildiz-Pekoz (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2021-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

In COVID-19-induced acute respiratory distress syndrome, the lungs are incapable of filling with sufficient air, leading to hypoxemia that results in high mortality among hospitalized patients. In clinical trials, low-molecular-weight heparin was administered via a specially designed soft-mist inhal...